Promising new therapies are springing up to treat ovarian cancer, long one of the most deadly and hard to treat malignancies. The latest: An experimental drug from Tesaro, a small biotech company based in Waltham, Mass. The company on Wednesday … Read more
With the number of cancer survivors growing every day, the question of what to eat after a cancer diagnosis is quickly becoming a hot topic. Some survivors believe it is of little importance: they have already been through cancer, so … Read more
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Phase 3 NOVA trial of niraparib successfully achieved its primary endpoint of progression-free survival (PFS). This trial demonstrated that niraparib significantly prolonged PFS compared to control among patients who … Read more
Lack of exercise is associated with an increased risk of ovarian cancer and of death from the disease, two new studies suggest. “Women may be overwhelmed with mixed messages about physical activity or exercise recommendations and opt to be inactive
… Read moreYou’ve probably heard the adage that you are more likely to regret the things you didn’t do than the things you did. Maybe there’s a long lost love that got away, a career you wish you had pursued, a trip
… Read moreIncreased collaboration and a willingness to see beyond the expected will be critical to the success of the national cancer moonshot initiative, Vice President Joe Biden told ASCO Annual Meeting attendees this afternoon. “No single oncologist or cancer researcher can … Read more
ASCO’s (American Society of Clinical Oncology) Annual Meeting was held on June 2nd through June 7th in Chicago, Illinois. ASCO offers premier scientific events for oncology professionals, patients, patient advocates, industry representatives, and major media outlets worldwide. It showcased new … Read more
Inside each ovarian tumor, there are good cells and bad cells. A new paper explains their roles: The bad cells are fibroblasts. They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment. … Read more
A meta-analysis of 346 phase I clinical trials involving more than 13,000 patients found that patients whose treatment was selected based on the molecular characteristics of their tumor had significantly better outcomes. The study was featured in a press briefing … Read more
Ovarian cancer is a fear of most women, largely due to the abysmal prognosis once it is found. The reasons for this are clearly understood — the more advanced a cancer is when it is discovered, the more difficult it … Read more
“Ovarian cancer is the most feared gynecologic cancer,” says Teresa Diaz-Montes, MD, associate director of the Lya Segall Ovarian Cancer Institute at Mercy Medical Center in Baltimore, MD. Perhaps that’s for good reason: Often called the “silent killer,” the disease … Read more
Even as an increasing number of states approve the use of medical marijuana, a review of medical literature and existing data finds that huge questions remain about its true benefits and risks for patients with cancer.1 Investigators found that … Read more
For cancer patients undergoing alopecia-inducing chemotherapy, scalp cooling to reduce hair loss is safe, according to new research. “This is a treatment that women going into chemotherapy treatment need to know about,” said Mikel Ross, RN, BSN, from the Memorial … Read more
Designer will be at two local fashion events; Oasis runway to feature real women, with real bodies
Fashion designer Nicole Miller is known for her figure-flattering silhouettes. She’s also very flattering toward San Diego, where she’ll hold two events this … Read more
The Clearity Foundation is proud to partner with Smart Patients, an online community for patients and caregivers affected by cancer! Smart Patients is an online community for motivated patients and their families and friends. On their website you can learn … Read more
Three years ago, Vice President Joe Biden was sitting with President Xi Jinping of China in an empty restaurant in the city of Chengdu. Speaking through a translator, Xi asked him whether he could “define America.” Biden told Xi he … Read more
Kent Haffer remembers when his oncologist approached him with an unusual idea. It was 2013, and Haffer, a 55-year-old computer programmer living in St. Peters, Missouri, had been receiving treatment for advanced melanoma for eight years. His oncologist proposed that … Read more
Women’s cancer specialists from all over the world convened in San Diego in March to hear about the latest developments in women’s cancer research. This was the fifth SGO annual meeting I’ve attended over the past eight years, and the … Read more
Take Action by the end of the day on March 18th!
We have just learned that Rep. Anna Eshoo (D-CA) is circulating a letter supporting critical funding for the National Cancer Institute and we need your help TODAY to help … Read more
An estimated 22,280 women in the United States will be diagnosed with ovarian cancer this year and 14,240 women will die. Unfortunately, most women are not aware of the dangers or symptoms of ovarian cancer, and many realize they have … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
